MedTrace Logo

Glucose Homeostasis in Pseudohypoparathyroidism

NCT03761290 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2026-05-04

No results posted yet for this study

Summary

It is increasingly recognized that Pseudohypoparathyroidism type 1A (PHP1A) is associated with an increased risk of type 2 diabetes but the mechanism is unknown. In this pilot study we will assess β-cell function in patients with PHP1A and pseudopseudohypoparathyroidism PPHP.

Conditions

  • Pseudohypoparathyroidism and Pseudopseudohypoparathyroidism
  • Pseudohypoparathyroidism Type Ia
  • Albright Hereditary Osteodystrophy

Sponsors & Collaborators

Principal Investigators

  • Ashley H Shoemaker, MD · Vanderbilt University Medical Center

Eligibility

Min Age
6 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-19
Primary Completion
2021-04-30
Completion
2021-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03761290 on ClinicalTrials.gov